| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2615cd73a750bed25d63085b90cdb827 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f66b3970657c5c2f137fa8e34e9ab92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d50b952067f932de546b249c89b1211a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057cd39d33715fab1a5c5f19c0e2d7c5 |
| publicationDate |
2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113166121-A |
| titleOfInvention |
A kind of solid form, crystalline form, A crystal form of FXR agonist and preparation method and application thereof |
| abstract |
The invention discloses a solid form, a crystal form, a crystal form of a compound of formula (I) as an FXR receptor agonist and a preparation method thereof, and also includes a compound of formula (I) in the preparation of the treatment of nonalcoholic steatohepatitis ( NASH) drug application. |
| priorityDate |
2018-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |